Litio en Psiquiatría. / Lithium in Psychiatry.

Descripción del Articulo

Background: Lithium is a light, metallic element and minerals containing it are most abundant in the Andes. John Cade introduced lithium carbonate for the treatment of mania in 1949, opening the era of modern clinical psychopharmacology. Lithium remains the most extensively studied mood-stabilizing...

Descripción completa

Detalles Bibliográficos
Autores: Baldessarini, Ross J., Tondo, Leonardo
Formato: artículo
Fecha de Publicación:2014
Institución:Universidad Peruana Cayetano Heredia
Repositorio:Revistas - Universidad Peruana Cayetano Heredia
Lenguaje:español
OAI Identifier:oai:revistas.upch.edu.pe:article/1167
Enlace del recurso:https://revistas.upch.edu.pe/index.php/RNP/article/view/1167
Nivel de acceso:acceso abierto
id REVUPCH_01365527e5bc6ed107dbab20e51175da
oai_identifier_str oai:revistas.upch.edu.pe:article/1167
network_acronym_str REVUPCH
network_name_str Revistas - Universidad Peruana Cayetano Heredia
repository_id_str
spelling Litio en Psiquiatría. / Lithium in Psychiatry.Baldessarini, Ross J.Tondo, LeonardoBackground: Lithium is a light, metallic element and minerals containing it are most abundant in the Andes. John Cade introduced lithium carbonate for the treatment of mania in 1949, opening the era of modern clinical psychopharmacology. Lithium remains the most extensively studied mood-stabilizing agent. It has had a revolutionary impact in supporting bipolar manic-depressive disorder as a discrete diagnosis, and on psychiatric therapeutics. Methods: We survey the development of lithium treatment in psychiatry, including findings concerning effects on suicide. Results: Lithium is the most extensively studied treatment for bipolar disorder and the prototypical mood-stabilizing agent, despite emergence of anticonvulsants and modern antipsychotics. In addition to limiting recurrences of mania, and some reduction of recurrences of bipolar depression, lithium has demonstrated protective effects against suicide. All treatments for bipolar disorder have notable limitations, including sometimes serious adverse effects, incomplete prevention of recurrences of mania and limited prevention of depression, which accounts for three-quarters of the approximately 50% time-ill in long-term follow-up with standard treatments. Lithium can be toxic in untreated overdoses; safe dosing requires monitoring of serum concentrations. Lithium also may have mild teratogenic effects, but far less than those of anticonvulsants used for bipolar disorder. Conclusions: Lithium opened the era of modern psychopharmacology and continues as the best-established mood-stabilizing treatment for bipolar disorder as well as having strong evidence of suicide-preventing effects.Universidad Peruana Cayetano Heredia2014-02-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistas.upch.edu.pe/index.php/RNP/article/view/116710.20453/rnp.v76i4.1167Revista de Neuro-Psiquiatria; Vol. 76 No. 4 (2013): Octubre - Diciembre; 189Revista de Neuro-Psiquiatría; Vol. 76 Núm. 4 (2013): Octubre - Diciembre; 189Revista de Neuro-Psiquiatria; v. 76 n. 4 (2013): Octubre - Diciembre; 1891609-73940034-8597reponame:Revistas - Universidad Peruana Cayetano Herediainstname:Universidad Peruana Cayetano Herediainstacron:UPCHspahttps://revistas.upch.edu.pe/index.php/RNP/article/view/1167/1199info:eu-repo/semantics/openAccessoai:revistas.upch.edu.pe:article/11672015-12-04T12:28:02Z
dc.title.none.fl_str_mv Litio en Psiquiatría. / Lithium in Psychiatry.
title Litio en Psiquiatría. / Lithium in Psychiatry.
spellingShingle Litio en Psiquiatría. / Lithium in Psychiatry.
Baldessarini, Ross J.
title_short Litio en Psiquiatría. / Lithium in Psychiatry.
title_full Litio en Psiquiatría. / Lithium in Psychiatry.
title_fullStr Litio en Psiquiatría. / Lithium in Psychiatry.
title_full_unstemmed Litio en Psiquiatría. / Lithium in Psychiatry.
title_sort Litio en Psiquiatría. / Lithium in Psychiatry.
dc.creator.none.fl_str_mv Baldessarini, Ross J.
Tondo, Leonardo
author Baldessarini, Ross J.
author_facet Baldessarini, Ross J.
Tondo, Leonardo
author_role author
author2 Tondo, Leonardo
author2_role author
description Background: Lithium is a light, metallic element and minerals containing it are most abundant in the Andes. John Cade introduced lithium carbonate for the treatment of mania in 1949, opening the era of modern clinical psychopharmacology. Lithium remains the most extensively studied mood-stabilizing agent. It has had a revolutionary impact in supporting bipolar manic-depressive disorder as a discrete diagnosis, and on psychiatric therapeutics. Methods: We survey the development of lithium treatment in psychiatry, including findings concerning effects on suicide. Results: Lithium is the most extensively studied treatment for bipolar disorder and the prototypical mood-stabilizing agent, despite emergence of anticonvulsants and modern antipsychotics. In addition to limiting recurrences of mania, and some reduction of recurrences of bipolar depression, lithium has demonstrated protective effects against suicide. All treatments for bipolar disorder have notable limitations, including sometimes serious adverse effects, incomplete prevention of recurrences of mania and limited prevention of depression, which accounts for three-quarters of the approximately 50% time-ill in long-term follow-up with standard treatments. Lithium can be toxic in untreated overdoses; safe dosing requires monitoring of serum concentrations. Lithium also may have mild teratogenic effects, but far less than those of anticonvulsants used for bipolar disorder. Conclusions: Lithium opened the era of modern psychopharmacology and continues as the best-established mood-stabilizing treatment for bipolar disorder as well as having strong evidence of suicide-preventing effects.
publishDate 2014
dc.date.none.fl_str_mv 2014-02-24
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistas.upch.edu.pe/index.php/RNP/article/view/1167
10.20453/rnp.v76i4.1167
url https://revistas.upch.edu.pe/index.php/RNP/article/view/1167
identifier_str_mv 10.20453/rnp.v76i4.1167
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistas.upch.edu.pe/index.php/RNP/article/view/1167/1199
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Peruana Cayetano Heredia
publisher.none.fl_str_mv Universidad Peruana Cayetano Heredia
dc.source.none.fl_str_mv Revista de Neuro-Psiquiatria; Vol. 76 No. 4 (2013): Octubre - Diciembre; 189
Revista de Neuro-Psiquiatría; Vol. 76 Núm. 4 (2013): Octubre - Diciembre; 189
Revista de Neuro-Psiquiatria; v. 76 n. 4 (2013): Octubre - Diciembre; 189
1609-7394
0034-8597
reponame:Revistas - Universidad Peruana Cayetano Heredia
instname:Universidad Peruana Cayetano Heredia
instacron:UPCH
instname_str Universidad Peruana Cayetano Heredia
instacron_str UPCH
institution UPCH
reponame_str Revistas - Universidad Peruana Cayetano Heredia
collection Revistas - Universidad Peruana Cayetano Heredia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1847421194567942144
score 12.63363
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).